Literature DB >> 30179294

Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring.

Michelle T Long1, Ellen B Gurary2, Joseph M Massaro2, Jiantao Ma3, Udo Hoffmann4, Raymond T Chung5, Emelia J Benjamin6,7, Rohit Loomba8.   

Abstract

BACKGROUND & AIMS: Little is known regarding the risk of hepatic steatosis (HS) among adult children of affected parents. We examined the association between parental and offspring HS in the multigenerational Framingham Heart Study, which characterized HS using computed tomography.
METHODS: We performed multivariable logistic regression models adjusted for age, sex, alcohol use, and body mass index to generate the odds of HS according to parental HS. We determined the proportion of participants with HS according to parental HS and the presence or absence of hypertension, diabetes, or obesity (BMI ≥30 kg/m2 ). After excluding heavy alcohol use (n = 126) and missing covariates (n = 1), 785 offspring with at least one parent were included.
RESULTS: Approximately 23% (183/785) had at least one parent with HS and 1.1% had two affected parents (9/785). In adjusted models, participants with at least one parent with HS had a nearly two-fold increased odds of HS compared to participants without a parental history of HS (OR 1.86, 95% confidence interval 1.15-3.03). Among participants without hypertension, diabetes, or obesity, a higher proportion had HS if they had a parental history of HS compared to those without (16.1% vs 5.2%, P < 0.001). However, for participants with cardiometabolic risk factors, we did not observe a difference in HS among those with and without parental HS (30.3% vs 28.5%, P = 0.78).
CONCLUSIONS: Individuals with a parental history of HS are at increased risk for HS. Specifically, a parental history of HS may be an important factor among those that are otherwise metabolically healthy.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  computed tomography; disease risk; familial; fatty liver disease; heritability

Year:  2018        PMID: 30179294      PMCID: PMC6758911          DOI: 10.1111/liv.13956

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  39 in total

1.  Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease.

Authors:  Paola Dongiovanni; Salvatore Petta; Cristina Maglio; Anna Ludovica Fracanzani; Rosaria Pipitone; Enrico Mozzi; Benedetta Maria Motta; Dorota Kaminska; Raffaela Rametta; Stefania Grimaudo; Serena Pelusi; Tiziana Montalcini; Anna Alisi; Marco Maggioni; Vesa Kärjä; Jan Borén; Pirjo Käkelä; Vito Di Marco; Chao Xing; Valerio Nobili; Bruno Dallapiccola; Antonio Craxi; Jussi Pihlajamäki; Silvia Fargion; Lars Sjöström; Lena M Carlsson; Stefano Romeo; Luca Valenti
Journal:  Hepatology       Date:  2015-02       Impact factor: 17.425

Review 2.  Non-alcoholic fatty liver disease and risk of cardiovascular disease.

Authors:  Amedeo Lonardo; Silvia Sookoian; Carlos J Pirola; Giovanni Targher
Journal:  Metabolism       Date:  2015-09-25       Impact factor: 8.694

3.  PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome.

Authors:  J Shen; G L-H Wong; H L-Y Chan; H-Y Chan; D K-W Yeung; R S-M Chan; A M-L Chim; A W-H Chan; P C-L Choi; J Woo; W C-W Chu; V W-S Wong
Journal:  Aliment Pharmacol Ther       Date:  2014-01-13       Impact factor: 8.171

4.  The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.

Authors:  Yaron Rotman; Christopher Koh; Joseph M Zmuda; David E Kleiner; T Jake Liang
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

Review 5.  Genetic and environmental factors in relative body weight and human adiposity.

Authors:  H H Maes; M C Neale; L J Eaves
Journal:  Behav Genet       Date:  1997-07       Impact factor: 2.805

6.  The heritability of alcohol use disorders: a meta-analysis of twin and adoption studies.

Authors:  B Verhulst; M C Neale; K S Kendler
Journal:  Psychol Med       Date:  2014-08-29       Impact factor: 7.723

7.  Heritability of nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Manuel A Celedon; Joel E Lavine; Rany Salem; Nzali Campbell; Nicholas J Schork; Masoud Shiehmorteza; Takeshi Yokoo; Alyssa Chavez; Michael S Middleton; Claude B Sirlin
Journal:  Gastroenterology       Date:  2009-01-25       Impact factor: 22.682

8.  Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease.

Authors:  Jiantao Ma; Rachel Hennein; Chunyu Liu; Michelle T Long; Udo Hoffmann; Paul F Jacques; Alice H Lichtenstein; Frank B Hu; Daniel Levy
Journal:  Gastroenterology       Date:  2018-03-29       Impact factor: 22.682

9.  Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study.

Authors:  Jeffrey Cui; Chi-Hua Chen; Min-Tzu Lo; Nicholas Schork; Ricki Bettencourt; Monica P Gonzalez; Archana Bhatt; Jonathan Hooker; Katherine Shaffer; Karen E Nelson; Michelle T Long; David A Brenner; Claude B Sirlin; Rohit Loomba
Journal:  Hepatology       Date:  2016-07-25       Impact factor: 17.425

10.  Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins.

Authors:  Janne Makkonen; Kirsi H Pietiläinen; Aila Rissanen; Jaakko Kaprio; Hannele Yki-Järvinen
Journal:  J Hepatol       Date:  2009-02-18       Impact factor: 25.083

View more
  8 in total

1.  Factors early in life associated with hepatic steatosis.

Authors:  Sabrina Xin Zi Quek; Eunice Xiang-Xuan Tan; Yi Ping Ren; Mark Muthiah; Evelyn Xiu Ling Loo; Elizabeth Huiwen Tham; Kewin Tien Ho Siah
Journal:  World J Hepatol       Date:  2022-06-27

Review 2.  Physical exercise and liver "fitness": Role of mitochondrial function and epigenetics-related mechanisms in non-alcoholic fatty liver disease.

Authors:  Jelena Stevanović; Jorge Beleza; Pedro Coxito; António Ascensão; José Magalhães
Journal:  Mol Metab       Date:  2019-11-29       Impact factor: 7.422

Review 3.  Genetic Contribution to Non-alcoholic Fatty Liver Disease and Prognostic Implications.

Authors:  Katherine Martin; Anas Hatab; Varinder S Athwal; Elliot Jokl; Karen Piper Hanley
Journal:  Curr Diab Rep       Date:  2021-02-05       Impact factor: 4.810

Review 4.  Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring.

Authors:  Natalia Balassiano Wajsbrot; Nathalie Carvalho Leite; Gil F Salles; Cristiane A Villela-Nogueira
Journal:  World J Gastroenterol       Date:  2022-07-07       Impact factor: 5.374

5.  Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction.

Authors:  Amedeo Lonardo; Ashwani K Singal; Natalia Osna; Kusum K Kharbanda
Journal:  Metab Target Organ Damage       Date:  2022-08-22

Review 6.  Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors.

Authors:  Oriol Juanola; Sebastián Martínez-López; Rubén Francés; Isabel Gómez-Hurtado
Journal:  Int J Environ Res Public Health       Date:  2021-05-14       Impact factor: 3.390

Review 7.  Nutrigenomics and Nutrigenetics in Metabolic- (Dysfunction) Associated Fatty Liver Disease: Novel Insights and Future Perspectives.

Authors:  Marcello Dallio; Mario Romeo; Antonietta Gerarda Gravina; Mario Masarone; Tiziana Larussa; Ludovico Abenavoli; Marcello Persico; Carmelina Loguercio; Alessandro Federico
Journal:  Nutrients       Date:  2021-05-15       Impact factor: 5.717

Review 8.  Novel Insights into the Genetic Landscape of Nonalcoholic Fatty Liver Disease.

Authors:  Alice Emma Taliento; Marcello Dallio; Alessandro Federico; Daniele Prati; Luca Valenti
Journal:  Int J Environ Res Public Health       Date:  2019-08-01       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.